BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 2 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 2 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT
Analysis

Three companies that are haunted by multiple lawsuits

Several companies have battled lawsuits from time to time for various reasons. However, sometimes companies face thousands of lawsuits for one reason. Here is a look at three companies that continue to be plagued by multiple lawsuits and face possibilities of huge penalties: Johnson & Johnson Johnson & Johnson (NYSE: JNJ) faces around 50,000 cases […]

September 17, 2019 2 min read
Analysis

Several companies have battled lawsuits from time to time for various reasons. However, sometimes companies face thousands of lawsuits for one reason. Here is a look at three companies that continue to be plagued by multiple lawsuits and face possibilities of huge penalties: Johnson & Johnson Johnson & Johnson (NYSE: JNJ) faces around 50,000 cases […]

Several companies have battled lawsuits from time to time
for various reasons. However, sometimes companies face thousands of lawsuits
for one reason. Here is a look at three companies that continue to be plagued
by multiple lawsuits and face possibilities of huge penalties:

Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) faces around 50,000 cases on several of its products from talc to artificial hips to blood thinner Xarelto. Forbes has estimated the cost of settling all these lawsuits at $6 billion. Apart from this, last month, Johnson & Johnson was ordered to pay $572 million for its role in the opioid crisis in Oklahoma.

J&J’s litigation expenses increased to $2 billion in 2018
from $1.3 billion in 2017. As the litigation expense increases, it continues to
increasingly impact earnings. At the end of the second quarter of 2019, the
company had cash of $14.4 billion.

Although this amount is sufficient to settle the estimated
$6-billion cost of lawsuits, it still amounts to nearly half of the company’s
cash reserve and taking such a heavy cut does not bode well for the company. In
the trailing 52 weeks, the company’s stock has dropped 6%.

Monsanto-Bayer

When Bayer acquired Monsanto, it ended up taking on Monsanto’s
legal troubles. The German company reportedly faces
over 18,000 lawsuits
related to the weedkiller Roundup and could end up
paying around $8 billion to settle them. Bayer’s stock has dropped over 8% in
the past one year.

Last month, Bayer announced the sale of its animal health business to Elanco for $7.6 billion.

Also read: WeWork IPO delay: Causes and impact

Google

Alphabet’s (NYSE: GOOGL) subsidiary Google is another company that faces multiple lawsuits on various grounds. Google has been accused of several privacy violations and questionable data collection methods.

In July, the company settled two lawsuits, one related to alleged age discrimination and the other on grounds that its Street View vehicles collected private information from unsecured Wi-Fi networks. The first settlement amounted to $11 million and the second one totaled $13 million.

Google has various other lawsuits pending and the company also faces antitrust probes from 50 states. In the second quarter of 2019, Google’s revenue totaled $38 billion. While these litigation amounts appear to be miniscule compared to the company’s revenue, these expenses still take a toll on the earnings.

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips.

ADVERTISEMENT